[go: up one dir, main page]

WO2008134289A3 - Complexes de lanthanide insaturés de manière coordonnée à relaxivité élevée - Google Patents

Complexes de lanthanide insaturés de manière coordonnée à relaxivité élevée Download PDF

Info

Publication number
WO2008134289A3
WO2008134289A3 PCT/US2008/061078 US2008061078W WO2008134289A3 WO 2008134289 A3 WO2008134289 A3 WO 2008134289A3 US 2008061078 W US2008061078 W US 2008061078W WO 2008134289 A3 WO2008134289 A3 WO 2008134289A3
Authority
WO
WIPO (PCT)
Prior art keywords
lanthanide complexes
coordinatively unsaturated
high relaxivity
unsaturated lanthanide
relaxivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/061078
Other languages
English (en)
Other versions
WO2008134289A2 (fr
Inventor
Dennis A Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of WO2008134289A2 publication Critical patent/WO2008134289A2/fr
Publication of WO2008134289A3 publication Critical patent/WO2008134289A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La présente invention concerne des composés tétraazamacrocycliques et des complexes de lanthanide de ceux-ci utiles comme agents de contraste MRI ayant une relaxivité améliorée.
PCT/US2008/061078 2007-04-26 2008-04-22 Complexes de lanthanide insaturés de manière coordonnée à relaxivité élevée Ceased WO2008134289A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91405407P 2007-04-26 2007-04-26
US60/914,054 2007-04-26

Publications (2)

Publication Number Publication Date
WO2008134289A2 WO2008134289A2 (fr) 2008-11-06
WO2008134289A3 true WO2008134289A3 (fr) 2008-12-11

Family

ID=39760993

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/061078 Ceased WO2008134289A2 (fr) 2007-04-26 2008-04-22 Complexes de lanthanide insaturés de manière coordonnée à relaxivité élevée

Country Status (1)

Country Link
WO (1) WO2008134289A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11191854B2 (en) 2017-05-05 2021-12-07 Centre For Probe Development And Commercialization Pharmacokinetic enhancements of bifunctional chelates and uses thereof

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8865129B2 (en) 2011-05-05 2014-10-21 New York University Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof
US10207013B2 (en) 2014-03-17 2019-02-19 The Board Of Regents Of The University Of Texas Systems Gadolinium-based contrast agents for sensitive detection of Zn2+ with MRI
KR20240160664A (ko) 2017-05-05 2024-11-11 센터 포 프로브 디벨롭먼트 앤드 커머셜리제이션 Igf-1r 모노클로날 항체 및 그의 용도
US10093741B1 (en) 2017-05-05 2018-10-09 Fusion Pharmaceuticals Inc. IGF-1R monoclonal antibodies and uses thereof
CN114573609B (zh) * 2022-03-07 2024-02-06 桂林理工大学 一种基于不对称双核镝配合物的单分子磁体及其制备方法

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053503A (en) * 1989-02-17 1991-10-01 Centocor Chelating agents
CA2055093A1 (fr) * 1990-11-08 1992-05-09 Johannes Platzek Derives de mono-n-substituant-1,4,7,10-tetraazacyclododecane, procede d'obtention et agents pharmaceutiques qui contiennent de ces derives
WO1995024221A1 (fr) * 1986-08-18 1995-09-14 The Dow Chemical Company Conjugues dendrimeres bioactifs et/ou cibles
WO1995028392A1 (fr) * 1994-04-14 1995-10-26 Nycomed Salutar Inc. Composes chelateurs
WO1996011023A1 (fr) * 1994-10-10 1996-04-18 Nycomed Salutar Inc. Agents liposomiques
WO1996028433A1 (fr) * 1995-03-10 1996-09-19 Nycomed Imaging A.S Composes de polyazacycloalcane
WO2005062828A2 (fr) * 2003-12-23 2005-07-14 Bracco Imaging S.P.A. Nouveaux composes utiles comme chelateurs de metaux
WO2008073828A2 (fr) * 2006-12-08 2008-06-19 Northwestern University Compositions et procédés pour des produits de contraste d'imagerie par résonance magnétique
WO2008098056A2 (fr) * 2007-02-06 2008-08-14 Epix Pharmaceuticals, Inc. Chélate à haute relaxation high relaxivity chelates

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024221A1 (fr) * 1986-08-18 1995-09-14 The Dow Chemical Company Conjugues dendrimeres bioactifs et/ou cibles
US5053503A (en) * 1989-02-17 1991-10-01 Centocor Chelating agents
CA2055093A1 (fr) * 1990-11-08 1992-05-09 Johannes Platzek Derives de mono-n-substituant-1,4,7,10-tetraazacyclododecane, procede d'obtention et agents pharmaceutiques qui contiennent de ces derives
WO1995028392A1 (fr) * 1994-04-14 1995-10-26 Nycomed Salutar Inc. Composes chelateurs
WO1996011023A1 (fr) * 1994-10-10 1996-04-18 Nycomed Salutar Inc. Agents liposomiques
WO1996028433A1 (fr) * 1995-03-10 1996-09-19 Nycomed Imaging A.S Composes de polyazacycloalcane
WO2005062828A2 (fr) * 2003-12-23 2005-07-14 Bracco Imaging S.P.A. Nouveaux composes utiles comme chelateurs de metaux
WO2008073828A2 (fr) * 2006-12-08 2008-06-19 Northwestern University Compositions et procédés pour des produits de contraste d'imagerie par résonance magnétique
WO2008098056A2 (fr) * 2007-02-06 2008-08-14 Epix Pharmaceuticals, Inc. Chélate à haute relaxation high relaxivity chelates

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DESSOLIN J ET AL: "Tri-N-Boc-tetraazamacrocycle-nucleoside conjugates: synthesis and anti-HI activities", NUCLEOSIDES & NUCLEOTIDES, vol. 17, no. 5, 13 April 1998 (1998-04-13), pages 957 - 968, XP002094374, ISSN: 0732-8311 *
KARFELD L S ET AL: "Use of a genetically engineered protein for the design of a multivalent MRI contrast agent", BIOCONJUGATE CHEMISTRY, vol. 18, no. 6, November 2007 (2007-11-01), pages 1697 - 1700, XP009106214, ISSN: 1043-1802 *
ZECH S G ET AL: "Probing the water coordination of protein-targeted MRI contrast agents by pulsed ENDOR spectroscopy", CHEMPHYSCHEM - A EUROPEAN JOURNAL OF CHEMICAL PHYSICS & PHYSICALCHEMISTRY, vol. 6, no. 12, December 2005 (2005-12-01), pages 2570 - 2577, XP009105424, ISSN: 1439-4235 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11191854B2 (en) 2017-05-05 2021-12-07 Centre For Probe Development And Commercialization Pharmacokinetic enhancements of bifunctional chelates and uses thereof

Also Published As

Publication number Publication date
WO2008134289A2 (fr) 2008-11-06

Similar Documents

Publication Publication Date Title
WO2007115821A3 (fr) Composés organiques
WO2009077471A3 (fr) Azolylméthyloxiranes, leur utilisation et agents les contenant
WO2009077443A3 (fr) Azolylméthyloxiranes, leur utilisation et agents les contenant
IL187999A0 (en) Compositions for the treatment of persistent infections
WO2007077561A3 (fr) Compositions et procédés permettant d'améliorer le captage in-vivo d'agents pharmaceutiques
WO2009077500A3 (fr) Azolylméthyloxiranes, leur utilisation et agents les contenant
IL191137A0 (en) Polycation-polyanion complexes, compositions and methods of use thereof
WO2007001851A3 (fr) Préparations et méthodes pour le diagnostic et le traitement d'une tumeur
WO2011077043A3 (fr) Derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
TW200712051A (en) Mixture of diisononyl esters of 1,2-cyclohexanedicarboxylic acid, process for their preparation and use of these mixtures
WO2009077497A3 (fr) Azolylméthyloxiranes, utilisation de ceux-ci et agents contenant ceux-ci
WO2012016980A3 (fr) Utilisation de ligands sigma dans une hyperalgie induite par des opioïdes
IL198510A0 (en) Tricyclic heteroaryl compounds, compositions comprising the same and uses thereof
WO2007021937A3 (fr) Derives heterocycliques insatures
IL187565A0 (en) Compositions and methods for the treatment or prevention of chemoresistant neoplasia
WO2008134289A3 (fr) Complexes de lanthanide insaturés de manière coordonnée à relaxivité élevée
EP1876187A4 (fr) Preparation de complexes multinucleaires ferriques-saccharidiques
WO2007070613A3 (fr) Analogues de la rifamycine et leurs utilisations
EP1922345A4 (fr) Procede destine a la preparation d'un copolymere-1
WO2008009750A3 (fr) Composés macrocycliques utiles comme inhibiteurs de la bace
WO2008019030A8 (fr) Composés d'azole modifiés en tant qu'agents anti-infectieux
WO2007139833A3 (fr) Composés d'imidazo-azéphinone
WO2009137291A8 (fr) Spiroaza-indoles
IL192507A0 (en) Use of alpha-hydroxy carbonyl compounds as reducing agents
PT1984005E (pt) Uso de complexos de gálio para o tratamento de melanomas

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08746488

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08746488

Country of ref document: EP

Kind code of ref document: A2